POU5F1 and hepatocellular carcinoma: Additionally, stemness genes, such as Nanog, Sox2, and Oct4, were expressed in EpCAM-positive HCC cells and TSC2-AKT signaling activated upon Sorafenib treatment, further exacerbating hepatocellular carcinoma progression [33].